The Iceland-based generic pharmaceuticals company, Actavis, announced last week that it has entered into a binding letter of intent with QRxPharma to launch MoxDuo® IR in the United States. The product launch in the U.S. is expected in the third quarter of 2012. Claudio Albrecht, CEO of Actavis said, “This partnership ... Read More...
Recent Posts
- demicon takes home the 2020 Adaptavist Partner of the year award September 30, 2020
- Preventing infection spread in Iceland’s healthcare settings as data specialist’s Lýsir and Sani nudge partner September 15, 2020
- Good Agricultural and Collecting Practices (GACP) Certification Granted To Plena Global September 15, 2020
- RIFF announces its exciting 17th edition to be launched on 24th of September August 20, 2020
- Taxback International identifies the complexities in navigating international VAT reclamation July 29, 2020
Submit Your Press Release at eNewsWire
eNewsWire is an online press release service offering both free and paid distribution. eNewWire distributes business, organisational and personal news and press releases using the Internet. Submit your press release here.